Cisplatin ototoxicity: Examination of the impact of dosing, infusion times, and schedules in pediatric cancer patients

Authors

Miranda L Camet, Washington University School of Medicine in St. Louis
Anne Spence, Washington University School of Medicine in St. Louis
Susan S Hayashi, Washington University School of Medicine in St. Louis
Ningying Wu, Washington University School of Medicine in St. Louis
Jennifer Henry, Washington University School of Medicine in St. Louis
Kara Sauerburger, Washington University School of Medicine in St. Louis
Robert J Hayashi, Washington University School of Medicine in St. Louis

Journal

Frontiers in Oncology

Publication Date

1-1-2021

Volume

11

First Page

673080

Document Type

Open Access Publication

DOI

10.3389/fonc.2021.673080

Rights and Permissions

Camet ML, Spence A, Hayashi SS, Wu N, Henry J, Sauerburger K and Hayashi RJ (2021) Cisplatin Ototoxicity: Examination of the Impact of Dosing, Infusion Times, and Schedules In Pediatric Cancer Patients. Front. Oncol. 11:673080. doi: 10.3389/fonc.2021.673080 © 2021 Camet, Spence, Hayashi, Wu, Henry, Sauerburger and Hayashi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Recommended Citation

Camet, Miranda L; Spence, Anne; Hayashi, Susan S; Wu, Ningying; Henry, Jennifer; Sauerburger, Kara; and Hayashi, Robert J, "Cisplatin ototoxicity: Examination of the impact of dosing, infusion times, and schedules in pediatric cancer patients." Frontiers in Oncology. 11, 673080 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10515